All posts tagged
Will BMS Take Over a Danish Biotech in a Massive €500M Deal?
More News! Will BMS be acquired? “CRISPR babies aren’t unethical”?
French Biotech’s Checkpoint Inhibitor Fails Phase II Leukemia Trial
A Combination of Checkpoint Inhibitors triggers new Milestone Payment
The Largest Deals, Fundraising and Exits of 2016 in European Biotech
BMS Offers €850M for a British Oncolytic Virus better than CAR-T
Microbiomics recruited for Immuno-Oncology in a Huge New Partnership
Boehringer buys a €210M ticket to Virus-based Immuno-Oncology
BMS to combine Immuno-Oncology Blockbuster with Oxford Biotech
New Massive €250M Investment Fund Closed for European Biotech
A French Biotech is Monopolising Immuno-Oncology with Big Euro Deals
Money Money Money for Immuno-Oncology: BMS Joins up with a Top German VC
Labiotech UG, All Rights Reserved -
Send this to friend